Trials / Terminated
TerminatedNCT01875770
Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This research is being done to assess the long term prognosis of patients treated with ranibizumab for edema due to retinal vein occlusion.
Detailed description
People treated with ranibizumab for edema due to retinal vein occlusion as part of previous studies at the Wilmer Eye Institute and who are currently being seen by their ophthalmologist at the Wilmer Eye Institute are followed up to assess long term outcomes
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2018-10-11
- Completion
- 2021-03-03
- First posted
- 2013-06-12
- Last updated
- 2021-10-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01875770. Inclusion in this directory is not an endorsement.